Brookmont Capital Management

Position in AZN — Astrazeneca PLC

CIK 1512978 Dallas, TX

Position in AZN

as of Jun 30, 2026 · filed Jul 24, 2026 Compact

Position Value

$5,012,794

-$120,250 QoQ

Shares Held

26,436

+1.6% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

2.81%

of 13F equity value

Holder Rank

#396

of 1,462 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Brookmont Capital Management holds $13,411,938 across 3 Drug Manufacturers - General names. AZN ranks #1 (37.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AZN	Astrazeneca PLC This page	26,436	$5,012,794
2	GILD	Gilead Sciences, Inc.	37,837	$4,780,326
3	JNJ	Johnson & Johnson	14,249	$3,618,818

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$5,012,794	26,436	+1.6%	Shares	Sole	2026-07-24
2026-03-31	$5,133,044	26,027	—	Shares	Sole	2026-05-15
No filing history on record for this holder in this stock.